Abstract
Specific-pathogen-free B6D2 F1 hybrid mice were treated orally with tilorone hydrochloride (100 mg/kg of body weight per day) and infected with sublethal doses of Listeria monocytogenes, Salmonella enteritidis, Mycobacterium bovis (BCG Pasteur), or M. tuberculosis Erdman. Daily tilorone treatment inhibited the cell-mediated response to all of the intracellular parasites, and most of the mice succumbed to the challenge. Tilorone suppressed delayed hypersensitivity responses to the microbial sensitins as well as to sheep erythrocytes. However, humoral responses (immediate hypersensitivity reactions) were stimulated. The types of growth curves obtained in the tilorone-treated mice were quite different from those observed in T-cell-depleted mice and tended to resemble those seen in sublethally irradiated (400 rads) animals. Leukocyte counts were depressed 10-fold by daily tilorone treatment. Both monocyte and granulocyte (but not large-lymphocyte) counts were depressed. There was an initial drop in small-lymphocyte counts with a later recovery phase. Tilorone treatment reduced the granulomatous response within the Salmonella-infected liver, suggesting that the drug interferes with the mobilization of the mononuclear defenses within the normal host.
Full text
PDF







Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cheers C., Waller R. Activated macrophages in congenitally athymic "nude mice" and in lethally irradiate mice. J Immunol. 1975 Sep;115(3):844–847. [PubMed] [Google Scholar]
- Collins F. M., Auclair L., Montalbine V. Effect of T-cell depletion on the growth of BCG in the mouse footpad. Int Arch Allergy Appl Immunol. 1975;48(5):680–690. doi: 10.1159/000231355. [DOI] [PubMed] [Google Scholar]
- Collins F. M. Cellular antimicrobial immunity. CRC Crit Rev Microbiol. 1978;7(1):27–91. doi: 10.3109/10408417909101177. [DOI] [PubMed] [Google Scholar]
- Collins F. M. Effect of tilorone treatment on intracellular microbial infections in specific-pathogen-free mice. Antimicrob Agents Chemother. 1975 Apr;7(4):447–452. doi: 10.1128/aac.7.4.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Collins F. M., Mackaness G. B. Delayed hypersensitivity and arthus reactivity in relation to host resistance in salmonella-infected mice. J Immunol. 1968 Nov;101(5):830–845. [PubMed] [Google Scholar]
- Collins F. M., Mackaness G. B. The relationship of delayed hypersensitivity to acquired antituberculous immunity. I. Tuberculin sensitivity and resistance to reinfection in BCG-vaccinated mice. Cell Immunol. 1970 Sep;1(3):253–265. doi: 10.1016/0008-8749(70)90047-x. [DOI] [PubMed] [Google Scholar]
- Collins F. M. Vaccines and cell-mediated immunity. Bacteriol Rev. 1974 Dec;38(4):371–402. doi: 10.1128/br.38.4.371-402.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
- De Clercq E., Merigan T. C. Bis-DEAE-fluorenone: mechanism of antiviral protection and stimulation of interferon production in the mouse. J Infect Dis. 1971 Feb;123(2):190–199. doi: 10.1093/infdis/123.2.190. [DOI] [PubMed] [Google Scholar]
- Gibson J. P., Megel H., Camyre K. P., Michael J. G. Effect of tilorone hydrochloride on the lymphoid and interferon responses of athymic mice. Proc Soc Exp Biol Med. 1976 Feb;151(2):264–266. doi: 10.3181/00379727-151-39188. [DOI] [PubMed] [Google Scholar]
- Gruenewald R., Levine S. Effect of tilorone on susceptibility of mice to primary or secondary infection with Listeria monocytogenes. Infect Immun. 1976 Jun;13(6):1613–1618. doi: 10.1128/iai.13.6.1613-1618.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Levine S., Gibson J. P., Megel H. Selective depletion of thymus dependent areas in lymphoid tissue by tilorone. Proc Soc Exp Biol Med. 1974 May;146(1):245–248. doi: 10.3181/00379727-146-38079. [DOI] [PubMed] [Google Scholar]
- Megel H., Raychaudhuri A., Goldstein S., Kinsolving C. R., Shemano I., Michael J. G. Tilorone: its selective effects on humoral and cell-mediated immunity. Proc Soc Exp Biol Med. 1974 Feb;145(2):513–518. doi: 10.3181/00379727-145-37842. [DOI] [PubMed] [Google Scholar]
- Megel H., Raychaudhuri A., Thomas L. L. The effect of tilorone on the local graft-versus-host reaction in rats. Transplantation. 1976 Jan;21(1):81–83. [PubMed] [Google Scholar]
- Miller T. E., Mackaness G. B., Lagrange P. H. Immunopotentiation with BCG. II. Modulation of the response to sheep red blood cells. J Natl Cancer Inst. 1973 Nov;51(5):1669–1676. doi: 10.1093/jnci/51.5.1669. [DOI] [PubMed] [Google Scholar]
- Morrison N. E., Collins F. M. Immunogenicity of an aerogenic BCG vaccine in T-cell-depleted and normal mice. Infect Immun. 1975 May;11(5):1110–1121. doi: 10.1128/iai.11.5.1110-1121.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Munson A. E., Munson J. A., Regelson W., Wampler G. L. Effect of Tilorone hydrochloride and congeners on reticuloendothelial system, tumors, and the immune response. Cancer Res. 1972 Jul;32(7):1397–1403. [PubMed] [Google Scholar]
- Raff M. C. Two distinct populations of peripheral lymphocytes in mice distinguishable by immunofluorescence. Immunology. 1970 Oct;19(4):637–650. [PMC free article] [PubMed] [Google Scholar]
- Raychaudhuri A., Megel H. The effect of tilorone on immunoglobulin-bearing lymphocytes (B cells) in peripheral blood and spleens of mice. J Reticuloendothel Soc. 1976 Aug;20(2):127–134. [PubMed] [Google Scholar]
- Volkman A., Collins F. M. Recovery of delayed-type hypersensitivity in mice following suppressive doses of X-radiation. J Immunol. 1968 Nov;101(5):846–859. [PubMed] [Google Scholar]
- Wildstein A., Stevens L. E., Hashim G. Skin and heart allograft prolongation in tilorone-treated rats. Transplantation. 1976 Feb;21(2):129–132. doi: 10.1097/00007890-197602000-00007. [DOI] [PubMed] [Google Scholar]

